’ "    The lack of transparency has its pros and cons. On the one hand,   having these contracts under wraps keeps a drug manufacturer from   knowing what its competitor is getting as a rebate. If it knew,   the company could argue it shouldn’t have to pay a bigger rebate   than the other. " 